Picard Medical is trading 9.52% up at $4.83, although no explicit catalyst has been identified.
- Searches found no clearly dated September 10, 2026 company announcement explaining the move.
- The latest confirmed quarterly release, dated August 19, reported revenue growth, a lower net loss, and improved gross margin, but did not explain the current session’s price action.